Atlas Trials

Alternative Schedule Sunitinib in Metastatic Renal Cell Carcinoma: Cardiopulmonary Exercise Testing

Clinical trial NCT03109015 · COMPLETED

Trial details

NCT number
NCT03109015
Sponsor
Duke University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Renal Cell
Start date
2017-09-27
Primary completion
2019-10-08
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.